Siga Technologies Inc. (NASDAQ:SIGA – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Investors acquired 1,200 call options on the stock. This is an increase of 1,438% compared to the average volume of 78 call options.
Siga Technologies Price Performance
NASDAQ:SIGA opened at $6.85 on Thursday. Siga Technologies has a 12 month low of $4.95 and a 12 month high of $9.62. The firm has a market capitalization of $490.53 million, a PE ratio of 6.72 and a beta of 0.98. The business’s fifty day moving average price is $6.45 and its 200 day moving average price is $7.45.
Siga Technologies (NASDAQ:SIGA – Get Free Report) last released its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) earnings per share (EPS) for the quarter. Siga Technologies had a return on equity of 35.23% and a net margin of 43.22%.The business had revenue of $2.62 million for the quarter. As a group, equities analysts anticipate that Siga Technologies will post 1.04 EPS for the current year.
Wall Street Analyst Weigh In
Check Out Our Latest Analysis on Siga Technologies
Institutional Trading of Siga Technologies
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. EP Wealth Advisors LLC lifted its position in shares of Siga Technologies by 44.1% during the 1st quarter. EP Wealth Advisors LLC now owns 20,018 shares of the company’s stock worth $110,000 after buying an additional 6,131 shares during the last quarter. Jane Street Group LLC lifted its position in Siga Technologies by 138.4% in the first quarter. Jane Street Group LLC now owns 114,147 shares of the company’s stock valued at $626,000 after acquiring an additional 66,265 shares during the last quarter. Strs Ohio acquired a new position in Siga Technologies in the first quarter valued at $165,000. Wealth Enhancement Advisory Services LLC acquired a new position in Siga Technologies in the second quarter valued at $394,000. Finally, Kapitalo Investimentos Ltda purchased a new position in shares of Siga Technologies during the second quarter worth about $183,000. Institutional investors and hedge funds own 55.40% of the company’s stock.
About Siga Technologies
Siga Technologies, Inc (NASDAQ: SIGA) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of medical countermeasures for public health emergencies and biological threats. The company’s flagship product, TPOXX® (tecovirimat), is the first and only antiviral approved by the U.S. Food and Drug Administration for the treatment of smallpox. Siga has entered into procurement and development contracts with U.S. government agencies, including the Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense, to supply TPOXX® for the Strategic National Stockpile.
Founded in 2002, Siga has built a pipeline of therapies targeting high-consequence pathogens such as smallpox, plague and other potential biothreat agents.
See Also
- Five stocks we like better than Siga Technologies
- You Still Think Silver’s a Joke? Watch What Happens Next.
- A U.S. “birthright” claim worth trillions – activated quietly
- A month before the crash
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Siga Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siga Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
